在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

No tariffs on targeted cancer drugs will reduce the price pain for patients

China Daily | Updated: 2018-03-22 07:07
Share
Share - WeChat

Premier Li Keqiang promises zero tariff rates for targeted cancer drugs at a news conference after the two sessions in Beijing on Tuesday. Thepaper.cn comments:

It is estimated more than 2 million people die of cancer in China each year. If there are zero tariffs, the retail price of the imported lifesaving drugs used in targeted cancer therapies will drop markedly. Their high prices have resulted in a large number of cancer patients exhausting their savings to extend their lives for a short time.

Some imported targeted cancer therapies can cost a patient as much as 10,000 yuan ($1,579) a dose as they are not covered by the medical insurance system. The high prices mean many patients have to give up their treatment.

More and more patients have turned to buying medicines from India through various channels as the prices are much lower, or to generic drugs that are lower in both price and efficiency. They then take the medicines at home without professional instruction and monitoring, further risking their health.

Aside from the tariffs, the high retail price of imported drugs in China is also pushed up by agents' fees, value-added tax, and high basic prices, which stem from the super-national treatment that some foreign medicines have been enjoying in the drug procurement of public hospitals, even if some of their patent protections have expired.

The pledge to end the tariffs on targeted cancer therapies indicates that the government recognizes they are special goods concerning people's welfare. But even without the tariffs, there still remains considerable room to squeeze the profit links between customs and patients to further bring down the prices of the drugs.

That the government has to open doors to imported drugs to save people's lives should also ring alarm bells for domestic pharmaceutical companies, especially the State-owned ones, as they have no reasons to sit idle, and are obliged to strengthen their research into these badly needed medicines and try their best to acquire the ability of producing them as early as possible.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 九九热这里有精品 | 国产二区视频 | 国产精品看片 | 亚洲一区二区三区久久 | 91麻豆精品国产91久久久资源速度 | 手机看片369 | 色综合99| 欧美日韩亚洲视频 | 国产视频久久久久 | 国产精品久久在线观看 | 亚洲欧美日本在线 | 热re99久久精品国产99热 | 中文字幕一区二区三区四区 | 午夜激情视频 | 亚洲伊人久久综合 | 午夜免费视频 | 国产黄色在线播放 | 精品一区二区三区四区五区 | 国产日韩欧美视频 | 午夜激情视频 | 日韩国产一区二区三区 | 国产一区二区三区高清 | 成人日韩| 色999视频 | 欧美一区二区在线观看 | 免费xxxxx在线观看网站软件 | 免费在线一区二区三区 | 成人一区二区在线 | 日韩三级电影在线观看 | 久久男人 | 男女国产视频 | 国产伦理一区二区 | 国产精品国产三级国产aⅴ入口 | 中文字幕三级在线看午夜 | 91精品国产99久久久 | 性视频网站免费 | 国产精品一区二区三区免费观看 | 欧美性猛交xxxx免费看漫画 | 欧美日韩国产精品一区二区 | 日韩欧美一区二区三区免费观看 | 久久久精品电影 |